| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.7B | $27.5B | $28.1B | — | — | — | — | $22.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $7.6B | $6.3B | $5.4B | $5.8B | $8.0B | $5.0B | $6.9B | $7.1B |
| EPS (Basic) | $4.62 | $3.79 | $3.27 | $3.69 | $5.11 | $3.06 | $4.16 | $4.15 |
| EPS (Diluted) | $4.62 | $3.79 | $3.27 | $3.69 | $5.10 | $3.06 | $4.16 | $4.14 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $692.3B | $678.3B | $663.5B | $674.8B | $573.3B | $553.9B | $495.4B | $467.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $626.7B | $619.3B | $607.7B | $623.6B | $517.9B | $500.2B | $442.9B | $415.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $65.2B | $58.6B | $55.3B | $50.8B | $54.9B | $53.1B | $51.9B | $51.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.0B | $11.3B | $8.4B | $21.1B | $9.9B | $3.7B | $4.9B | $10.6B |
| Investing Cash Flow | $-20.5B | $-24.5B | $18.9B | $7.5B | $-57.5B | $-15.4B | $-21.6B | $-9.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $2.3B | $8.6B | $-19.7B | $-4.0B | $13.9B | $51.9B | $17.6B | $0.4B |